DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus.
Melanie ThompsonSonya L HeathBentley SweetonKathy WilliamsPamela CunninghamBrandon F KeeleSharon SenBrent E PalmerNicolas ChomontYongxian XuRahul BasuMichael S HellersteinSuefen KwaHarriet L RobinsonPublished in: PloS one (2016)
clinicaltrials.gov NCT01378156.